Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00240877 · ClinicalTrials.gov registry record · Phase 3
Study to Evaluate the Safety of a Monovalent Vaccine of a New 6:2 Reassortant in Healthy Adults (AV024)
A Phase 3 study, sponsored by MedImmune.
- Completed
- Registry status
- Phase 3
- Development phase
- 330
- Enrollment target
NCT00240877: Completed Phase 3 study, sponsored by MedImmune.
NCT00240877 is a Phase 3 study that has completed, run by MedImmune. The registered enrollment target is 330 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00240877, a Phase 3 study, has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 330 participants
- Enrollment target
Study Summary
To assess the safety of a vaccine in healthy adults prior to the release of the trivalent vaccine (FluMist).
Interventions
- OTHER Placebo
- BIOLOGICAL AV024
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2002-08 |
| Est. Completion | 2004-04 |
| Phase | Phase 3 |
What the finished NCT00240877 record still lists
NCT00240877 is an interventional study that assigns participants to a tested intervention. The registered 330 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (57% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00240877 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00240877 about?
NCT00240877 is a clinical study titled "Study to Evaluate the Safety of a Monovalent Vaccine of a New 6:2 Reassortant in Healthy Adults (AV024)". To assess the safety of a vaccine in healthy adults prior to the release of the trivalent vaccine (FluMist).
What is the current status of trial NCT00240877?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 330 participants. The study started on 2002-08. Estimated completion is 2004-04.
What interventions are being tested in trial NCT00240877?
The interventions under investigation include: Placebo (OTHER), AV024 (BIOLOGICAL).
Who is sponsoring clinical trial NCT00240877?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00240877's enrollment target sits among peer trials
330 1066th of 2000 higher than 927 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00359684 · 330 participants
Use of Cysteamine in the Treatment of Cystinosis
- NCT03817502 · 330 participants · Phase 3
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
- NCT03922724 · 330 participants · Phase 2
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
- NCT03932773 · 330 participants · NA
Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia